These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17714119)

  • 1. Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
    Schmid-Wendtner MH; Korting HC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1013-8. PubMed ID: 17714119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new oral antifungal agents for onychomycosis of the toenails.
    Gupta AK; Shear NH
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
    Gupta AK; Ryder JE; Johnson AM
    Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The systemic treatment of onychomycosis.
    Wenig JA
    Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
    Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M
    Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The systemic treatment of onychomycosis.
    Wenig JA
    Clin Podiatr Med Surg; 2004 Oct; 21(4):579-89, vi. PubMed ID: 15450898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in onychomycosis therapy: a literature review.
    Hecker D
    Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
    Gupta AK
    Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toenail onychomycosis: current and future treatment options.
    Finch JJ; Warshaw EM
    Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal infections and their management.
    Graybill JR; Sharkey PK
    Br J Clin Pract Suppl; 1990 Sep; 71():23-31. PubMed ID: 1965416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of systemic antimycotics in dermatotherapy.
    Niewerth M; Korting HC
    Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of onychomycosis in children.
    Gupta AK; De Rosso JQ
    Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis: pathogenesis, diagnosis, and management.
    Elewski BE
    Clin Microbiol Rev; 1998 Jul; 11(3):415-29. PubMed ID: 9665975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
    Chang CH; Young-Xu Y; Kurth T; Orav JE; Chan AK
    Am J Med; 2007 Sep; 120(9):791-8. PubMed ID: 17765049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treatment options for onychomycosis.
    Joseph WS
    J Am Podiatr Med Assoc; 1997 Nov; 87(11):520-31. PubMed ID: 9397657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral therapeutic agents in fungal nail disease.
    Roberts DT
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S78-81. PubMed ID: 8077514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.